You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 1800 results
 
  • Record 1 TO 1000
  • Record 1001 TO 1800

  1. Kinetic Biomarker for CLL Prognosis

    SBC: KINEMED, INC.            Topic: N/A

    DESCRIPTION (provided by applicant) PHASE I The need for reliable biomarkers in cancer is clear, for areas including prognosis, stratification, therapeutic monitoring and drug discovery and approval. The fundamental disorder in cancer is altered cell k

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  2. Technology for Culture of Megathura crenulata for KLH

    SBC: Stellar Biotechnologies, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The continuing goal of this project is to produce reliable and large-scale supplies of medical grade, quality-controlled Keyhole Limpet Hemocyanin (KLH) products ready for use in an expanding array of cancer vacci

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  3. Potentiating an Anthrax DNA Vaccine with Electroporation

    SBC: ICHOR MEDICAL SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Anthrax, an infectious disease caused by Bacillus anthracis, became a pressing concern because of its potential biowarfare use, most likely via aerosolized anthrax spore dissemination, resulting in deadly inhalation a

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  4. Phenotype MicroArrays for Drug Toxicity Screening

    SBC: BIOLOG, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II SBIR grant, we propose to develop our Phenotype MicroArray (PM) technology into a high throughput screening (HTS) assay for drug toxicity. The proposal addresses a key need in drug discovery for fas

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  5. Acetylator-based Individualized Dosing of Amonadife

    SBC: XANTHUS LIFE SCIENCES, INC.            Topic: N/A

    Chemotherapeutic dosing has traditionally been empiric, with all patients receiving the same dose adjusted for body surface area (BSA). Unfortunately, while this may be adequate for the average person, it can be inappropriate for the majority of patien

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  6. Real-time PolScope microscope for live-cell imaging

    SBC: CAMBRIDGE RESEARCH AND INSTRUMENTATION            Topic: N/A

    DESCRIPTION (provided by applicant): Phase I We propose to develop an ultra-sensitive real-time polarized light microscope ("Real-Time PolScope") for analyzing the dynamics of the molecular architecture in living cells, in whole organisms and in cell-f

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  7. N/A

    SBC: Schafer Corporation            Topic: N/A

    N/A

    SBIR Phase II 1999 Department of Health and Human Services

  8. Improving Healthcare Efficiency using Real Time Location

    SBC: RADIANSE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Radianse Inc. (formerly Sentinel Wireless, LLC) has created an automatic, continuous, real-time indoor positioning system (IPS) specifically for the healthcare environment. The IPS is installed on standard networks

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  9. Tritum AMS Analysis of Cancer Biomarkers

    SBC: NEWTON SCIENTIFIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this Phase II STTR program is to develop a high-throughput, ultra-sensitive accelerator mass spectrometer for the detection and quantification of tritium in labeled biological molecules. Accelerator mass s

    SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health

  10. Tritum AMS Analysis of Cancer Biomarkers

    SBC: NEWTON SCIENTIFIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this Phase II STTR program is to develop a high-throughput, ultra-sensitive accelerator mass spectrometer for the detection and quantification of tritium in labeled biological molecules. Accelerator mass spectrometry (AMS) is a highly selective means for detecting tritium that can achieve a measurement sensitivity over 1000 times greater than decay ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government